Event Calendar
Prev MonthPrev Month Next MonthNext Month
Hand Eczema Virtual Symposium
Wednesday, March 17, 2021, 12:30 PM - 2:00 PM CST
Category: IEC Events (for everyone)


MARCH 17, 2021 | 12:30 pm CDT | 1:30 pm EDT | 5:30 pm GMT | 6:30 pm CET  

Learn about chronic hand eczema during this complimentary educational symposium. An internationally renowned panel of experts will discuss the diagnosis, management and future treatment strategies for chronic hand eczema.

This program is supported in part by an educational grant from Leo Pharma.

Watch On-Demand Webcast


  • Robert Bissonnette, MD FRCPC, Innovaderm, Montreal, QC, Canada
  • Tove Agner, MD DMSc, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
  • David Cohen, MD MPH, New York University School of Medicine, New York, NY, USA


Welcoming Remarks
Emma Guttman, MD PhD, New York, NY, USA

Chronic Hand Eczema: Epidemiology, Etiology and Classification
April Armstrong, MD MPH, Los Angeles, CA, USA

How to Run a Hand Eczema Clinic
Tove Agner, MD DMSc, Copenhagen, Denmark

Hand Eczema - Contact Dermatitis
David E. Cohen, MD MPH, New York, NY, USA

Tools to Measure Hand Eczema Severity
Robert Bissonnette, MD FRCPC, Montreal, QC, CA

Current Therapeutic Strategies, Phototherapy, and Systemic Therapy
Jonathan Silverberg, MD PhD MPH, Washington, DC, USA

New Topical and Systemic Treatments for Chronic Hand Eczema 
Emma Guttman, MD PhD, New York, NY, USA

Q&A and Panel Discussion

This program will be recorded for future viewing.


Robert Bissonnette, MD FRCPC

Robert Bissonnette, MD FRCPC, is Board certified in dermatology and the president of Innovaderm Research—a contract research organization (CRO) specializing in the design, conduct, and analysis of clinical trials in various areas of dermatology—in Montreal, QC, Canada. He has published more than 140 articles and book chapters and has been involved in the development of many topical and systemic drugs for atopic dermatitis.

Dr. Bissonnette earned his medical degree from the University of Montreal, underwent residency training in dermatology at the University of Montreal, and completed his basic and clinical research training at McGill University and the University of British Columbia. He was an associate professor of dermatology at the University of Montreal until 2004.


Tove AgnerTove Agner, MD PhD

Tove Agner is a professor at the University of Copenhagen and a consultant for the Department of Dermatology at Bispebjerg Hospital in Copenhagen, Denmark. She researches skin barrier function with a special interest in contact dermatitis and atopic dermatitis—especially hand eczema, including irritant contact dermatitis and hand eczema caused by or aggravated by occupational exposures. Dr. Agner leads a research group with several PhD students at Bispebjerg Hospital and has co-authored more than 200 scientific papers registered in PubMed.


David CohenDavid E. Cohen, MD MPH

David Cohen is the Charles C. and Dorothea E. Harris professor and vice chairman for clinical affairs for the Ronald O. Perelman Department of Dermatology of New York University School of Medicine and leads the section on occupational and environmental dermatology. He joined the NYU faculty in 1994, and his work has concentrated on inflammatory skin diseases, cutaneous allergic and toxic reactions to exogenous and photoreactive chemicals, and the interaction of environmental stressors on the skin.

Dr. Cohen is the past president of the American Dermatological Association and has served as president of the American Contact
Dermatitis Society, the Dermatology Section of the New York Academy of Medicine, and the New York Dermatological Association. He has authored 113 articles and 22 book chapters and has lectured nationally and internationally on a variety of dermatologic disorders.

Dr. Cohen received his medical degree from the State University of New York at Stony Brook School of Medicine and his Master of Public Health from Columbia University. He served as an intern at Columbia Presbyterian Medical Center, a dermatology resident at New York University Medical Center, and a resident in occupational and environmental medicine at Columbia University School of Public Health.


Emma Guttman, MD PhD 

Emma Guttman, MD PhD, is the Waldman Professor and System Chair, Dermatology and Immunology, and director of both the Center of Excellence for Eczema and the Occupational Dermatitis Clinic and Laboratory for Inflammatory Skin Diseases at the Icahn School of Medicine at Mount Sinai Medical Center, New York.

Guttman’s major focus is atopic dermatitis (AD). She has:

  • made paradigm-shifting discoveries on the immunologic basis of AD in humans, enriching the understanding of its pathophysiology and opening the door to new therapeutics 
  • developed comprehensive molecular maps of AD, defining skin differentiation and immune-circuits characterizing this disease
  • established the reversibility of the AD phenotype 
  • defined a series of biomarkers that are now accelerating testing of novel pathway-specific drugs for AD.

She earned her doctor of medicine degree from Sackler in Tel-Aviv, Israel, and a doctor of philosophy degree from Bar-Ilan University in Israel. After receiving her board certification in dermatology in Israel, Guttman moved to the United States to pursue a postdoctoral fellowship at The Rockefeller University in New York, NY, and a second dermatology residency at Weill Cornell Medicine in New York, NY.

In addition to serving as president and co-founder of the International Eczema Council (IEC), Guttman was elected to the American Society for Clinical Investigation (ASCI) and the American Academy of Dermatology (AAD). Among other honors, she received the AAD Young Investigator Award in 2011.

April ArmstrongApril W. Armstrong, MD MPH

April Armstrong is associate dean of clinical research at Keck School of Medicine at the University of Southern California. She also is the director of clinical research for the Southern California Clinical and Translational Research Institute. In the Department of Dermatology at the University of Southern California, she serves as vice chair, director of clinical trials and outcomes research, and director of the psoriasis program.

For her research focus, Dr. Armstrong is particularly interested in the appropriate use of systemic agents, comparative effectiveness research, technology-enabled healthcare delivery, and comorbidities associated with inflammatory skin diseases. She is a federally funded investigator with extensive clinical trial experience, having led or collaborated on more than 120 studies. She has authored more than 150 peer-reviewed scientific publications and has been an editor for the top pharmacology textbook Principles of Pharmacology.

Dr. Armstrong has held multiple leadership positions at professional societies and has been part of the editorial boards of JAMA Dermatology, Journal of the American Academy of Dermatology, and Telemedicine and eHealth. She is a past president of Sacramento Valley Dermatologic Society.

Dr. Armstrong obtained her medical degree from Harvard Medical School and completed her dermatology residency at the Harvard Dermatology Residency Program. She also obtained a Master of Public Health degree from Harvard School of Public Health.

Jonathan SilverbergJonathan Silverberg, MD PhD MPH

An associate professor of dermatology, Jonathan Silverberg is the director of clinical research and contact dermatitis at The George Washington University School of Medicine and Health Sciences in Washington, DC.

His area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. He has extensive experience in the advanced management of atopic dermatitis, hand eczema, chronic itch, psoriasis, hidradenitis and many other chronic inflammatory skin disorders. He also is a national expert in allergy patch testing, phototesting, and photopatch testing.

Dr. Silverberg’s publications include more than 600 peer-reviewed articles, abstracts, and book chapters. He also is the author of Clinical Management of Atopic Dermatitis (2018).